GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RegeneRx Biopharmaceuticals RGRX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on RegeneRx Biopharmaceuticals

Our reporting

We have not reported on RegeneRx Biopharmaceuticals yet.

Past results

Reported against what analysts expected

30 Mar 202330 Dec 202229 Sept 202230 Mar 202230 Dec 202115 Nov 2021
Earnings per share-0.00-0.00-0.00-0.00-0.00-0.00
Revenue$19,190$19,190$19,190$19,191$19,190$19,190

Key events

  1. 18 Oct 2023100-to-1 reverse split
  2. 23 Dec 1986Listed

RegeneRx Biopharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.